Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 32

Sort by

Sort Order Select

Journal Articles

Accuracy of a Bleeding Assessment Tool in Predicting the Diagnosis of an Inherited Bleeding Disorder: Systematic Review and Meta-Analysis

Ahmad Alhuniti, Heba Abdallah, Margaret L. Rand, Susan Kearney, Anjali A. Sharathkumar, Meera Sridharan, Zhen Wang, Rajiv K Pruthi

Blood (2024) 144 (Supplement 1): 1217.

https://doi.org/10.1182/blood-2024-202703

Published: 2024

Journal Articles

A Phase Ib Clinical Trial Investigating the Safety, Tolerability, and Pharmacokinetics of HX009，a Novel Bsab Dual Targeting PD-1 x CD47，in Patients with EBV + Non-Hodgkin Lymphoma (NHL)

Lin Gui, Keshu Zhou, Ting Liu, Yan Qin, Hongmei Jing, Wenyu Li, Yajun Li, Wenrong Huang, Zhen Wang, Xiuhua Sun, Quan Li, Faming Zhang, Henry Li, Lei Zhang, Peng Sun, Xinbao Gao, Yuankai Shi

Blood (2024) 144 (Supplement 1): 1741.

https://doi.org/10.1182/blood-2024-194771

Published: 2024

Journal Articles

Updated Results from a Phase I Trial of Amulirafusp Alfa (IMM0306) in Patients with Relapsed or Refractory CD20-Positive B-Cell Non-Hodgkin's Lymphoma

Yuankai Shi, Jianliang Yang, Yongping Song, Keshu Zhou, Zhiming Li, Mingzhi Zhang, Hongmei Jing, Zhen Wang, Li Yu, Wei Meng, Qiying Lu, Wenzhi Tian

Blood (2024) 144 (Supplement 1): 1632.

https://doi.org/10.1182/blood-2024-200499

Published: 2024

Journal Articles

One Tube 23 Color Full Spectral Flow Cytometry Panel in Detecting Minimal Residual Disease in Pediatric B-Cell Acute Lymphoblastic Leukemia

Kefei Wu, Zhen Wang, Yangyang Xie, Xiang Wang, Wenting Hu, Jiaoyang Cai, Lixia Ding, Benshang Li, Shuhong Shen

Blood (2023) 142 (Supplement 1): 1607.

https://doi.org/10.1182/blood-2023-181565

Published: 2023

Journal Articles

A Multicenter Phase2 Trial of Linperlisib in Relapsed or Refractory Peripheral T/NK Cell Lymphomas

Blood (2023) 142 (Supplement 1): 306.

https://doi.org/10.1182/blood-2023-180137

Published: 2023

Journal Articles

A Phase Ib Study of Linperlisib Monotherapy in Patients with Relapsed or Refractory B-Cell Malignancies

Wei Liu, Yunhong Huang, Haiyan Yang, Zhiming Li, Zhen Cai, Zhen Wang, Lihong Liu, Ye Guo, Ligen Liu, Rui Huang, Xu Ye, Lugui Qiu

Blood (2023) 142 (Supplement 1): 1722.

https://doi.org/10.1182/blood-2023-177550

Published: 2023

Journal Articles

Patients with Asian-type DEL can safely be transfused with RhD-positive blood

Blood (2023) 141 (17): 2141–2150.

https://doi.org/10.1182/blood.2022018152

Published: 2023

Includes: Supplemental data

Journal Articles

Preliminary Safety and Efficacy Evaluation of IMM0306, a CD47 and CD20 Bispecific Monoclonal Antibody-Trap (mAb-Trap), from an Ongoing Phase I Dose-Escalation Study in Patients with Relapsed or Refractory B-Cell Non- Hodgkin's Lymphoma (R/R B-NHL)

Yuankai Shi, Yongping Song, Mingzhi Zhang, Hongmei Jing, Zhen Wang, Zhiming Li, Junyuan Qi, Fei Li, Wenyu Li, Jianliang Yang, Siman Gao, Huizi Ma, Heming He, Qiying Lu, Wenzhi Tian

Blood (2022) 140 (Supplement 1): 9323–9324.

https://doi.org/10.1182/blood-2022-157862

Published: 2022

Journal Articles

A Study of Linperlisib in the Treatment of Patients with Relapsed and/or Refractory Peripheral T-Cell Lymphoma

Lugui Qiu, Jie Jin, Hong Cen, Keshu Zhou, Xiaohong Xu, Fei Li, Tao Wu, Haiyan Yang, Zhen Wang, Zhiming Li, Hanying Bao, Zusheng Xu

Blood (2022) 140 (Supplement 1): 9395–9396.

https://doi.org/10.1182/blood-2022-162127

Published: 2022

Journal Articles

Efficacy and Safety of Recombinant Human-Mouse Chimeric Anti-CD20 Monoclonal Antibody (SCT400) Combined with CHOP in Patients with Treatment-Naïve Diffuse Large B-Cell Lymphoma: A Multicenter, Randomized, Single-Blind, Parallel Active-Controlled, Phase III Study

Blood (2021) 138 (Supplement 1): 2480.

https://doi.org/10.1182/blood-2021-149861

Published: 2021

Journal Articles

A Phase Ib Study of Linperlisib in Patients with Relapsed or Refractory Peripheral T-Cell Lymphoma

Jie Jin, Hong Cen, Keshu Zhou, Xiaohong Xu, Fei Li, Haiyan Yang, Zhiming Li, Hanying Bao, Zusheng Xu, Lugui Qiu, Yang Shu, Fei Li, Zhen Wang

Blood (2021) 138 (Supplement 1): 1386.

https://doi.org/10.1182/blood-2021-150215

Published: 2021

Journal Articles

Zanubrutinib, Lenalidomide Plus R-CHOP (ZR 2 -CHOP) As the First-Line Treatment for Diffused Large B-Cell Lymphoma (DLBCL)

Huayuan Zhu, Yeqin Sha, Wei Wu, Jingyan Qiu, Yilian Yang, Chen Peng, Chongyang Ding, Zhen Wang, Lei Fan, Wei Xu, Jianyong Li

Blood (2021) 138 (Supplement 1): 3559.

https://doi.org/10.1182/blood-2021-150510

Published: 2021

Journal Articles

A Phase1b Clinical Study of the Oral PI3Kδ Inhibitor, Linperlisib, in Patients with B-Cell Lymphomas

Lugui Qiu, Zhiming Li, Yunhong Huang, Ligen Liu, Lihong Liu, Ye Guo, Lan Deng, Haiyan Yang, Zhen CAI, Xu Ye, Zhen Wang, Hanying Bao, Zusheng Xu, Binghua Zheng

Blood (2021) 138 (Supplement 1): 3576.

https://doi.org/10.1182/blood-2021-148276

Published: 2021

Journal Articles

The Type II Glycoengineered Humanized Anti-CD20 Monoclonal Antibody MIL62 Combined with Lenalidomide in Chinese Patients with Relapsed/Refractory Follicular Lymphoma and Marginal Zone Lymphoma: Results of a Multicenter, Single-Arm, Phase 1b/2 Trial

Yuankai Shi, Yan Qin, Yongping Song, Keshu Zhou, Hui Zhou, Hongmei Jing, Ying Xiang, Zhao Wang, Zhen Wang, Aimin Zang, Ou Bai, Zhenyu Li, Huilai Zhang

Blood (2021) 138 (Supplement 1): 1351.

https://doi.org/10.1182/blood-2021-146440

Published: 2021

Journal Articles

BTK Inhibitor Ibrutinib/Zanubrutinib Plus Bendamustine and Rituximab As the Initial Treatment for Chronic Lymphocytic Leukemia/ Small Lymphocytic Leukemia：a Single Arm Real-World Study

Huayuan Zhu, Wei Wu, Yeqin Sha, Ze Jin, Yilian Yang, Jingyan Qiu, Chongyang Ding, Zhen Wang, Chuanbing Shi, Chen Peng, Hongling Mi, Ruize Chen, Li Wang, Lei Fan, Wei Xu, Jianyong Li

Blood (2021) 138 (Supplement 1): 4697.

https://doi.org/10.1182/blood-2021-152147

Published: 2021

Journal Articles

Sex Differences in Faculty Rank and Leadership Positions Amongst Hematologists and Oncologists in United States: A Cross-Sectional Study

Irbaz Riaz, MDMMSc, Rabbia Siddiqi, MBBS, Umar Zahid, MD MPH, Urshila Durani, MDMPH, Kaneez Fatima, MD, Qurat Ul Ain Riaz Sipra, MBBS, MD, Ammad Raina, DO, Muhammad Zain Farooq, MD MBBS, Alanna Chamberlain, Zhen Wang, Ronald S. Go, MD, Faisal Khosa, MD, Ariela L. Marshall, MD

Blood (2019) 134 (Supplement_1): 3399.

https://doi.org/10.1182/blood-2019-130670

Published: 2019

Journal Articles

Allogeneic CAR-T Cell Therapy for Treatment of Relapse after Allo-HSCT in Patients with Refractory CML Lymphoid Blast Crisis: Significance of HLA Matched Donor/Patient Pair in the Safety/Efficacy of CAR-T Cell Therapy

Kai Sun, MD, Xuejun Zhang, MD, Zhen Wang, MD, Yuqing Chen, MD, Lei Zhang, MD, Wei Cheng, MD, Mingyue Shi, MD, Lei Huo, MD, Yanliang Bai, MD, Xiaona Niu, MD, Honggang Guo, MD, Jing Yang, MD, Chunrong Tong, MD, AlexH Chang, MD, PhD

Blood (2018) 132 (Supplement 1): 4275.

https://doi.org/10.1182/blood-2018-99-115768

Published: 2018

Journal Articles

Interim or End of Treatment FGD-PET Complete Response Does Not Have Adequate Predictive Value in Mature T/NK Cell Lymphoma

Tatyana Feldman, MD, Larysa Sanchez, MD, Patrick Toth, MD, David Panush, MD, Lori A Leslie, MD, Alan P Skarbnik, MD, Anthony R. Mato, MD, Kar Fai Chow, MD, Ricardo Parrondo, MD, Veronica Mariotti, MD, Sejal Kothadia, MD, Zhen Wang, MD, Miguel Gonzalez, MD, Pritish K. Bhattacharyya, MD, Xiao Yang, MD PhD, Themba Nyirenda, PhD, Ewelina Protomastro, MS, Lori A. Leslie, MD, Andre Goy, MD

Blood (2016) 128 (22): 1813.

https://doi.org/10.1182/blood.V128.22.1813.1813

Published: 2016

Journal Articles

A Study of Adherence to Restrictive RBC Transfusion and 30 Day Patient Outcomes

Zhen Wang, MD, Elaine Zhai, DO, Aleksic Sandra, MD, Kibola Adam, MD, Richard May, MD, Teja Ganta, MD, Mirela Feurdean, MD, Neil Kothari, MD, Victor Chang, MD

Blood (2016) 128 (22): 5037.

https://doi.org/10.1182/blood.V128.22.5037.5037

Published: 2016

Journal Articles

Autologous Stem Cell Transplantation As a Treatment Modality for Type 1 Cryoglobulinemia in Monoclonal Gammopathy of Renal Significance

Zhen Wang, MD, Noa Biran, MD, Alan P Skarbnik, MD, Andrew L. Pecora, MD, Michele L. Donato, MD, Scott D. Rowley, MD, David S. Siegel, MD PhD, David H. Vesole, MD PhD, Joshua R. Richter, MD

Blood (2016) 128 (22): 5835.

https://doi.org/10.1182/blood.V128.22.5835.5835

Published: 2016

NARROW

Accuracy of a Bleeding Assessment Tool in Predicting the Diagnosis of an Inherited Bleeding Disorder: Systematic Review and Meta-Analysis

A Phase Ib Clinical Trial Investigating the Safety, Tolerability, and Pharmacokinetics of HX009，a Novel Bsab Dual Targeting PD-1 x CD47，in Patients with EBV + Non-Hodgkin Lymphoma (NHL)

Updated Results from a Phase I Trial of Amulirafusp Alfa (IMM0306) in Patients with Relapsed or Refractory CD20-Positive B-Cell Non-Hodgkin's Lymphoma

One Tube 23 Color Full Spectral Flow Cytometry Panel in Detecting Minimal Residual Disease in Pediatric B-Cell Acute Lymphoblastic Leukemia

A Multicenter Phase2 Trial of Linperlisib in Relapsed or Refractory Peripheral T/NK Cell Lymphomas

A Phase Ib Study of Linperlisib Monotherapy in Patients with Relapsed or Refractory B-Cell Malignancies

Patients with Asian-type DEL can safely be transfused with RhD-positive blood

Preliminary Safety and Efficacy Evaluation of IMM0306, a CD47 and CD20 Bispecific Monoclonal Antibody-Trap (mAb-Trap), from an Ongoing Phase I Dose-Escalation Study in Patients with Relapsed or Refractory B-Cell Non- Hodgkin's Lymphoma (R/R B-NHL)

A Study of Linperlisib in the Treatment of Patients with Relapsed and/or Refractory Peripheral T-Cell Lymphoma

Efficacy and Safety of Recombinant Human-Mouse Chimeric Anti-CD20 Monoclonal Antibody (SCT400) Combined with CHOP in Patients with Treatment-Naïve Diffuse Large B-Cell Lymphoma: A Multicenter, Randomized, Single-Blind, Parallel Active-Controlled, Phase III Study

A Phase Ib Study of Linperlisib in Patients with Relapsed or Refractory Peripheral T-Cell Lymphoma

Zanubrutinib, Lenalidomide Plus R-CHOP (ZR 2 -CHOP) As the First-Line Treatment for Diffused Large B-Cell Lymphoma (DLBCL)

A Phase1b Clinical Study of the Oral PI3Kδ Inhibitor, Linperlisib, in Patients with B-Cell Lymphomas

The Type II Glycoengineered Humanized Anti-CD20 Monoclonal Antibody MIL62 Combined with Lenalidomide in Chinese Patients with Relapsed/Refractory Follicular Lymphoma and Marginal Zone Lymphoma: Results of a Multicenter, Single-Arm, Phase 1b/2 Trial

BTK Inhibitor Ibrutinib/Zanubrutinib Plus Bendamustine and Rituximab As the Initial Treatment for Chronic Lymphocytic Leukemia/ Small Lymphocytic Leukemia：a Single Arm Real-World Study

Sex Differences in Faculty Rank and Leadership Positions Amongst Hematologists and Oncologists in United States: A Cross-Sectional Study

Allogeneic CAR-T Cell Therapy for Treatment of Relapse after Allo-HSCT in Patients with Refractory CML Lymphoid Blast Crisis: Significance of HLA Matched Donor/Patient Pair in the Safety/Efficacy of CAR-T Cell Therapy

Interim or End of Treatment FGD-PET Complete Response Does Not Have Adequate Predictive Value in Mature T/NK Cell Lymphoma

A Study of Adherence to Restrictive RBC Transfusion and 30 Day Patient Outcomes

Autologous Stem Cell Transplantation As a Treatment Modality for Type 1 Cryoglobulinemia in Monoclonal Gammopathy of Renal Significance

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only